Global Immuno-Oncology Assay Market Comprehensive Analysis and Forecast 2023 to 2028

Yorumlar · 17 Görüntüler

Global Immuno-Oncology Assay Market Comprehensive Analysis and Forecast 2023 to 2028

Global Immuno-Oncology Assay Market Overview: 2023-2028

Base Year: 2022

Historical Years:  2018-21

Forecast Years: 2023-2028

The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The Global Immuno-Oncology Assay Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.

Markntel Advisor’s Global Immuno-Oncology Assay Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Immuno-Oncology Assay Market drivers, barriers, Global Immuno-Oncology Assay Market Trends, and Key Players in Global Immuno-Oncology Assay Market.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report - This paragraph to be added on Request sample Line and after then add   LINK OF SAMPLE

Global Immuno-Oncology Assay Market Dynamics: 2023-2028

Global Immuno-Oncology Assay Market Driver:

Increasing Cancer Cases Globally to Drive Immuno-Oncology Assay Market– The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory. For instance,

In 2018, the Global Cancer Observatory recorded approximately 18.1 million cancer cases worldwide, a number that escalated to approximately 19.2 million by 2020.

This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.

Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html

Global Immuno-Oncology Assay Market (2023-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Product & Services

Reagents and Antibodies- Market Size & Forecast 2018-2028F, USD Million

Testing Kits- Market Size & Forecast 2018-2028F, USD Million

Instruments- Market Size & Forecast 2018-2028F, USD Million

Consumables & Accessories- Market Size & Forecast 2018-2028F, USD Million

Software- Market Size & Forecast 2018-2028F, USD Million

By Assay Type

Checkpoint Inhibitor Assays- Market Size & Forecast 2018-2028F, USD Million

Cytokine Profiling Assays- Market Size & Forecast 2018-2028F, USD Million

Protein Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million

Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2018-2028F, USD Million

Immune Profiling Assays- Market Size & Forecast 2018-2028F, USD Million

Tumour Biomarker Assays-  Market Size & Forecast 2018-2028F, USD Million

Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2018-2028F, USD Million

By Technology

Polymerase Chain Reaction- Market Size & Forecast 2018-2028F, USD Million

Immunoassay- Market Size & Forecast 2018-2028F, USD Million

Next-generation Sequencing- Market Size & Forecast 2018-2028F, USD Million

In-situ Hybridization- Market Size & Forecast 2018-2028F, USD Million

Flow Cytometry- Market Size & Forecast 2018-2028F, USD Million

Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size & Forecast 2018-2028F, USD Million

By Indication

Lung Cancer- Market Size & Forecast 2018-2028F, USD Million

Breast Cancer- Market Size & Forecast 2018-2028F, USD Million

Colorectal Cancer- Market Size & Forecast 2018-2028F, USD Million

Prostate Cancer- Market Size & Forecast 2018-2028F, USD Million

Ovarian Cancer- Market Size & Forecast 2018-2028F, USD Million

Others (Bladder Cancer, Melanoma, etc.)- Market Size & Forecast 2018-2028F, USD Million

By Application

Clinical Assay- Market Size & Forecast 2018-2028F, USD Million

Research & Development- Market Size & Forecast 2018-2028F, USD Million

By End User

Hospitals- Market Size & Forecast 2018-2028F, USD Million

Cancer Research Centers- Market Size & Forecast 2018-2028F, USD Million

Specialty Cancer Clinics- Market Size & Forecast 2018-2028F, USD Million

Clinical Laboratories- Market Size & Forecast 2018-2028F, USD Million

Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2018-2028F, USD Million

By Region

North America

South America

Europe

Middle East & Africa

Asia-Pacific.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Immuno-Oncology Assay Market:

Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Yorumlar